Featured

Alexandria Venture Investments Join $10M Seed Financing For CrossBridge Bio

HOUSTON--(BUSINESS WIRE)--CrossBridge Bio, a biotechnology company pioneering dual-payload antibody-drug conjugates... Read more »

Duke U.’s DUMAC Joins $20M Round for Archon Biosciences

Pasadena, Calif.-based Alexandria Venture Investments, a subsidiary of Alexandria Real Estate Equities (NYSE: ARE), has... Read more »

Interview with Michael Koehler, Medical Director at Affinity Whole Health

Dr. Koehler is Affinity's Medical Director and a board-certified emergency medicine physician. A native Texan, Dr... Read more »

citybiz
Gain exposure through our multi-channel news platform.

Kincell Bio Appoints Stewart McNaull, PhD, As Chief Commercial Officer

United Therapeutics Corporation Reports Third Quarter 2024 Financial Results

Interview with Adam Low, CEO of SENTA Partners

CopilotIQ and Biofourmis Merge

Inhibikase Therapeutics Closes of $275 Million Financing

Quorum Health Acquires Odessa Regional Medical Center, Scenic Mountain Medical Center

OneOncology Acquires United Urology Group

Inhibikase Therapeutics Prices of $110 Million Private Placement

Maternal Health Startup Canopie Raises $3.7 Million

States That Vaccinate the Most in 2024 – WalletHub Study

Collegium Completes Acquisition of Ironshore Therapeutics

Versant Diagnostics Acquires Cutaneous Pathology, P.A.

Incyclix Bio Appoints Dr. Andrew Beelen As Vice President Of Clinical Development

North Carolina Places Eighth in Ranking of Biopharma Clusters

HealthCare Royalty and Blue Owl Announce $250M Debt Financing with TG Therapeutics

United Therapeutics Corporation Reports Second Quarter 2024 Financial Results